LOW DOSE ASPIRIN (1-50 MG) TOGETHER WITH ANTIPLATELETS SUCH AS TICAGRELOR OF ANTICOAGULANTS

摘要

The present disclosure concerns a dosage regimen consisting of ultra-low doses of irreversible cyclooxygenase inhibitors in combination with platelet aggregation inhibitors or anticoagulant agents for the prevention and treatment of acute coronary syndromes and other ischaemic events.